MABVAX THERAPEUTICS HOLDINGS, INC. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - February 27, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - MABVAX THERAPEUTICS HOLDINGS, INC.Financial_Report.xls
10-K - FORM 10-K - MABVAX THERAPEUTICS HOLDINGS, INC.d302514d10k.htm
EX-3.4 - REGISTRANT'S CERTIFICATE OF ELIMINATION - MABVAX THERAPEUTICS HOLDINGS, INC.d302514dex34.htm
EX-31.2 - CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) - MABVAX THERAPEUTICS HOLDINGS, INC.d302514dex312.htm
EX-32.1 - CERTIFICATION REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) - MABVAX THERAPEUTICS HOLDINGS, INC.d302514dex321.htm
EX-31.1 - CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) - MABVAX THERAPEUTICS HOLDINGS, INC.d302514dex311.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-44826, 333-58020, 333-118614, 333-135396 , 333-161132 and 333-174355) and the Registration Statement on Form S-3 (No. 333-176121) and in the related Prospectuses and Prospectus Supplements, of our report dated February 27, 2012, with respect to the financial statements of Telik, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2011.

/s/ ERNST & YOUNG LLP

San Jose, California

February 27, 2012

Stock widget

Investing forum

MABVAX THERAPEUTICS HOLDINGS, INC. Reports